The next board meeting for Tscan Therapeutics Inc is on 20 May 2026 for the purpose of TScan Therapeutics Inc Annual General Meeting for 2026See details
Tscan Therapeutics Inc has a share price target of US$ 6, revenue growth forecast of -34.8%, and profit growth estimate of 11.3% for FY26, based on top 6 analyst calls.